IFC Holdings Incorporated FL Raises Position in Medtronic PLC (MDT)
IFC Holdings Incorporated FL increased its stake in Medtronic PLC (NYSE:MDT) by 0.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,673 shares of the medical technology company’s stock after purchasing an additional 17 shares during the quarter. IFC Holdings Incorporated FL’s holdings in Medtronic PLC were worth $501,000 at the end of the most recent quarter.
A number of other large investors also recently bought and sold shares of the business. Parkside Financial Bank & Trust raised its stake in Medtronic PLC by 22.4% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,146 shares of the medical technology company’s stock valued at $102,000 after buying an additional 210 shares during the last quarter. Israel Discount Bank of New York bought a new position in shares of Medtronic PLC during the 1st quarter valued at $117,000. Birch Hill Investment Advisors LLC bought a new position in shares of Medtronic PLC during the 1st quarter valued at $120,000. Farmers National Bank bought a new position in shares of Medtronic PLC during the 1st quarter valued at $121,000. Finally, Norway Savings Bank boosted its stake in shares of Medtronic PLC by 2.7% in the 2nd quarter. Norway Savings Bank now owns 1,427 shares of the medical technology company’s stock worth $127,000 after buying an additional 38 shares during the last quarter. 80.63% of the stock is owned by institutional investors and hedge funds.
Medtronic PLC (MDT) opened at 78.11 on Wednesday. Medtronic PLC has a 1-year low of $69.35 and a 1-year high of $89.72. The company’s 50-day moving average is $80.57 and its 200 day moving average is $83.40. The stock has a market capitalization of $105.81 billion, a PE ratio of 26.29 and a beta of 1.01.
Medtronic PLC (NYSE:MDT) last posted its quarterly earnings data on Tuesday, August 22nd. The medical technology company reported $1.12 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.08 by $0.04. Medtronic PLC had a net margin of 13.75% and a return on equity of 12.92%. The business had revenue of $7.39 billion for the quarter, compared to the consensus estimate of $7.44 billion. During the same period last year, the firm posted $1.03 earnings per share. The company’s revenue was up 3.1% compared to the same quarter last year. Equities analysts predict that Medtronic PLC will post $4.77 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 20th. Stockholders of record on Friday, September 29th will be paid a dividend of $0.46 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.36%. Medtronic PLC’s dividend payout ratio is currently 61.95%.
MDT has been the topic of a number of research reports. BidaskClub raised Medtronic PLC from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 17th. Zacks Investment Research cut Medtronic PLC from a “hold” rating to a “sell” rating in a research report on Tuesday, September 12th. Jefferies Group LLC reissued a “buy” rating and issued a $103.00 target price on shares of Medtronic PLC in a report on Thursday, August 3rd. UBS AG reissued an “overweight” rating on shares of Medtronic PLC in a report on Thursday, August 24th. Finally, Royal Bank Of Canada reissued a “buy” rating and issued a $90.00 target price on shares of Medtronic PLC in a report on Monday, August 21st. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and fourteen have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $89.12.
COPYRIGHT VIOLATION WARNING: “IFC Holdings Incorporated FL Raises Position in Medtronic PLC (MDT)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/04/ifc-holdings-incorporated-fl-raises-position-in-medtronic-plc-mdt.html.
In related news, CEO Omar Ishrak sold 140,407 shares of the firm’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $81.63, for a total value of $11,461,423.41. Following the transaction, the chief executive officer now directly owns 668,503 shares of the company’s stock, valued at approximately $54,569,899.89. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Bryan C. Hanson sold 12,000 shares of the firm’s stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $88.57, for a total transaction of $1,062,840.00. The disclosure for this sale can be found here. 0.31% of the stock is owned by insiders.
About Medtronic PLC
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.
Receive News & Stock Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related stocks with our FREE daily email newsletter.